Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Are Pfizer's Earnings Better Than They Look?
Motley Fool
Saturday, September 24, 2011 - 12:48pm
tags:
Pfizer
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Yahoo/BusinessWire
Saturday, September 24, 2011 - 12:48pm
tags:
Seattle Genetics, Millennium, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma
3 Undervalued Healthcare Stocks Trading Near Highs
Seeking Alpha
Saturday, September 24, 2011 - 12:46pm
tags:
Medicis, Unitedhealth Group, Cephalon
Celgene’s Alkeran Extends Life in Eye-Cancer Patients in Study
Bloomberg
Saturday, September 24, 2011 - 12:44pm
tags:
eye cancer, Celgene, Alkeran, melphalan
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Saturday, September 24, 2011 - 12:43pm
tags:
vismodegib, Roche, basal cell carcinoma, skin cancer
StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter
Yahoo/GlobeNewswire
Saturday, September 24, 2011 - 12:42pm
tags:
StemCells, HuCNS-SC, spinal cord injury
MannKind to sell senior secured discount notes
Yahoo/AP
Saturday, September 24, 2011 - 12:41pm
tags:
MannKind
CHMP Recommends Astellas Pharma Europe Ltd.'s (APEL) DIFICLIR for Approval in the EU
Yahoo/PR NewsWire
Saturday, September 24, 2011 - 12:40pm
tags:
Optimer Pharmaceuticals, Astellas, Dificlir, Clostridium Difficile, fidaxomicin
How Long Does It Take to Make a Buck at Biogen Idec?
Motley Fool
Saturday, September 24, 2011 - 12:38pm
tags:
Biogen Idec
AstraZeneca Rep Is Sued By Nexium Patients
Pharmalot
Friday, September 23, 2011 - 12:28pm
tags:
AstraZeneca, Nexium, lawsuits
Enzon Pharmaceuticals Plans to Cut Almost Half of Its Workforce
Bloomberg
Friday, September 23, 2011 - 12:11pm
tags:
Enzon, layoffs
Calif. AG won't review finding in Medicis CEO girlfriend's death
Yahoo/AP
Friday, September 23, 2011 - 12:09pm
tags:
Medicis, Jonah Shacknai
ImmunoGen advances lymphoma drug candidate
Bizjournals.com
Friday, September 23, 2011 - 12:06pm
tags:
Immunogen, IMGN529, chronic lymphocytic leukemia, non-Hodgkin's lymphoma
Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Friday, September 23, 2011 - 12:03pm
tags:
Celgene, Revlimid, Europe, EU, Multiple Myeloma
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
WSJ Online
Friday, September 23, 2011 - 12:01pm
tags:
Eprex, anemia, recalls, JNJ
Europe Calls for Limits on Sanofi's Multaq
Motley Fool
Friday, September 23, 2011 - 11:59am
tags:
Sanofi, Multaq, Europe, EMA
Bristol CEO says "pure pharma" strategy paying off
Reuters
Friday, September 23, 2011 - 8:58am
tags:
Bristol-Myers Squibb, Pharma CEOs, Lamberto Andreotti
PharmAthene Wins Rights to Profit From Siga Smallpox Drug
Bloomberg
Friday, September 23, 2011 - 8:56am
tags:
PharmAthene, smallpox, SIGA technologies, ST-246
Could Merck Be Hiding Weakness?
Motley Fool
Friday, September 23, 2011 - 8:55am
tags:
Merck
Bayer’s Xarelto Wins EU Drug Panel Backing for Added Use
Bloomberg
Friday, September 23, 2011 - 8:55am
tags:
Bayer, bloodthinners, Xarelto, Europe

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.